The effect of remimazolam versus propofol on respiratory depression for non-intubated general anesthesia: a
Yutao Chen1,2, Siru Li1,2, Di Wang1
1Department of Anesthesiology, Central Hospital of Dalian University of Technology, No. 826 Southwest Road, Shahekou District, Dalian, Liaoning Province, China.
Background:
This randomized controlled trial aimed to compare the respiratory safety profiles of remimazolam versus propofol during non-intubated general anesthesia.
Methods:
This single-center, randomized controlled trial investigated 200 female patients undergoing Open Excision of Benign Breast Nodule (OEBN) under non-intubated general anesthesia. Participants were randomly assigned to receive either remimazolam or propofol for anesthesia induction and maintenance, combined with remifentanil. We employed the Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scale for continuous sedation monitoring. The primary endpoint was the incidence of respiratory depression. Secondary outcomes encompassed: postoperative recovery quality, sedation success rate, frequency of respiratory depression episodes, requirement for airway interventions, and occurrence of adverse events (including hemodynamic instability and procedure-related complications).
Results:
Of 200 randomized participants, 173 completed all study procedures and were included in the final analysis (Group R: n = 87; Group P: n = 86). The remimazolam group exhibited superior respiratory safety profiles compared to the propofol group, with a lower incidence of respiratory depression (89.7% vs 97.7%, p = 0.031) and a significantly reduced requirement for airway interventions (all p < 0.05). Furthermore, remimazolam predominantly induces mild respiratory depression (73.6%), whereas propofol is more frequently associated with severe respiratory suppression (44.2%). Regarding adverse events, Group R demonstrated markedly lower rates of injection pain (0% vs 39.5%, p < 0.001), hypotension (29.9% vs 46.5%, p = 0.024), and bradycardia (18.4% vs 44.2%, p < 0.001). Patients receiving remimazolam (Group R) demonstrated significantly superior hemodynamic stability compared to the propofol group.
Conclusion:
Although both remimazolam and propofol demonstrated a high incidence of respiratory depression, remimazolam was associated with milder respiratory suppression and a reduced need for airway interventions during OEBN with non-intubated general anesthesia. Additionally, it offers better hemodynamic stability and fewer adverse events, making it a safer alternative for such procedures.
Clinical Trial Registration:
ChiCTR2400089826.
More Related Videos
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
01:24Parenteral Anesthetics: Overview
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
01:22Stages of General Anesthesia
01:20Inhalational Anesthetics: Overview
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...